Trastuzumab Active Not Recruiting Phase 2 Trials for Advanced Breast Cancer / HER2 Amplified / Human Epidermal Growth Factor Receptor 2 (HER2) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02091960A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer